Annual Revenue
$25.55 M
+$24.16 M+1749.82%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual revenue is $25.55 million, with the most recent change of +$24.16 million (+1749.82%) on December 31, 2023.
- During the last 3 years, RLAY annual revenue has fallen by -$57.11 million (-69.09%).
- RLAY annual revenue is now -69.09% below its all-time high of $82.65 million, reached on December 31, 2020.
Performance
RLAY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 1, 2024
Summary
- RLAY quarterly revenue is not available.
Performance
RLAY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 1, 2024
Summary
- RLAY TTM revenue is not available.
Performance
RLAY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RLAY Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1749.8% | - | - |
| 3 y3 years | -69.1% | - | - |
| 5 y5 years | - | - | - |
RLAY Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1749.8% | ||||
| 5 y | 5-year | -69.1% | +1749.8% | ||||
| alltime | all time | -69.1% | +1749.8% |
Relay Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $10.01 M(<-9900.0%) | $35.33 M(+38.3%) |
| Dec 2023 | $25.55 M(+1749.8%) | -$1000.00(-100.0%) | $25.55 M(-1.0%) |
| Sep 2023 | - | $25.20 M(>+9900.0%) | $25.80 M(+2638.9%) |
| Jun 2023 | - | $119.00 K(-47.3%) | $942.00 K(-20.7%) |
| Mar 2023 | - | $226.00 K(-10.7%) | $1.19 M(-14.0%) |
| Dec 2022 | $1.38 M | $253.00 K(-26.5%) | $1.38 M(-18.5%) |
| Sep 2022 | - | $344.00 K(-5.8%) | $1.70 M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $365.00 K(-12.9%) | $2.02 M(-19.2%) |
| Mar 2022 | - | $419.00 K(-26.1%) | $2.50 M(-17.6%) |
| Dec 2021 | $3.03 M(-96.3%) | $567.00 K(-14.9%) | $3.03 M(-96.4%) |
| Sep 2021 | - | $666.00 K(-21.1%) | $85.12 M(+0.8%) |
| Jun 2021 | - | $844.00 K(-11.3%) | $84.45 M(+1.0%) |
| Mar 2021 | - | $952.00 K(-98.8%) | $83.61 M(+1.2%) |
| Dec 2020 | $82.65 M | $82.65 M | $82.65 M |
FAQ
- What is Relay Therapeutics annual revenue?
- What is the all time high annual revenue for Relay Therapeutics?
- What is Relay Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Relay Therapeutics?
- What is the all time high TTM revenue for Relay Therapeutics?
What is Relay Therapeutics annual revenue?
The current annual revenue of RLAY is $25.55 M
What is the all time high annual revenue for Relay Therapeutics?
Relay Therapeutics all-time high annual revenue is $82.65 M
What is Relay Therapeutics annual revenue year-on-year change?
Over the past year, RLAY annual revenue has changed by +$24.16 M (+1749.82%)
What is the all time high quarterly revenue for Relay Therapeutics?
Relay Therapeutics all-time high quarterly revenue is $82.65 M
What is the all time high TTM revenue for Relay Therapeutics?
Relay Therapeutics all-time high TTM revenue is $85.12 M